The Pharmacy Industry in Sola: Key Data and Development Trends

Executive Summary

The pharmacy industry in Sola is a stable and growing sector with 5 registered companies and 38 employees in 2023. Sales have grown from NOK 62.8 million in 2016 to NOK 113.8 million in 2025, with an average annual growth of 11.9%. EBITDA margins range between 1% and 7%, with variations between individual companies. The industry is dominated by AS companies, and there are no bankruptcy registrations among the registered companies. The development shows a mix of established and new players, with particular challenges for Apotek 1 Sola, which has zero sales in the reports.

Economic Overview

Sales Development (2016–2025):

Employee Development (2016–2026):

Sales have grown significantly after 2021, with a specific increase of 29.8% from 2022 to 2023. The number of employees has increased by 17.1% from 2025 to 2026, indicating an expected development in the future.

Companies in the Industry

In Sola, there are 5 registered companies in the pharmacy industry, all with the organizational form AS. The main companies are:

1. Sola Apotek As (Sola Center): 15 employees, sales of NOK 40.8 million, EBITDA of NOK 441.1 thousand.
2. Apotek 1 Tananger (Risavika Harbor Ring): 11 employees, sales of NOK 19.3 million, EBITDA of NOK 1.4 million.
3. Apotek 1 Sola (Solakrossen 15): 8 employees, but with zero sales and EBITDA.
4. Boots Apotek Tananger (Skibmannsvegen 3): 7 employees, sales of NOK 20.0 million, EBITDA of NOK 361.2 thousand.
5. Boots Apotek Sola (Solakrossen 13): 6 employees, sales of NOK 5.0 million, EBITDA of NOK 90.3 thousand.

Apotek 1 Sola and Boots Apotek Sola have lower sales and EBITDA compared to the other companies, which may indicate specific challenges for these players.

Industry Geography

The pharmacy industry in Sola is divided into two main areas:

1. Sola (3 companies):

• Total number of employees: 29
• Sales: NOK 45.8 million
• EBITDA: NOK 531.4 thousand
• EBITDA margin: 1%

1. Tananger (2 companies):

• Total number of employees: 18
• Sales: NOK 39.3 million
• EBITDA: NOK 1.8 million
• EBITDA margin: 4%

Tananger has a higher EBITDA margin compared to Sola, which may indicate better cost control or higher efficiency in this part of the municipality.

Industry Dynamics

Bankruptcy Statistics: None of the registered companies in the pharmacy industry in Sola have gone bankrupt, indicating a stable industry. However, the data show that Apotek 1 Sola has zero sales and EBITDA, which may indicate specific challenges for this company. It is important to note that this may be a unique situation and not necessarily a general trend in the industry.

Organizational Forms: All companies are registered as AS, indicating a standardized structure in the industry. There are no companies with other organizational forms such as Sole Proprietorships (Enkelt) or Partnerships (PS).

Outlook for Entrepreneurs

The pharmacy industry in Sola shows positive development with increasing sales and number of employees, especially from 2021 onwards. This indicates growing demand for pharmacy services in the municipality. EBITDA margins, however, are at a low level (1–7%), which may be a challenge for new players. Entrepreneurs should consider focusing on efficiency improvements and cost control to ensure profitability.

There are also opportunities to develop specialized services or to leverage the population growth in Sola. SmartGrunder can help entrepreneurs find suitable addresses and locations in the municipality to start or expand a pharmacy business.

Conclusion

The pharmacy industry in Sola is a stable and growing sector with 5 companies and 38 employees in 2023. Sales have grown significantly after 2021, and there are no bankruptcy registrations among the registered companies. Outlooks for new players are positive, but it is important to be aware of the low EBITDA margins and specific challenges for certain companies. SmartGrunder can help entrepreneurs find suitable locations and addresses in the municipality to start or expand a pharmacy business.